Taurochenodeoxycholic acid induces NR8383 cells apoptosis via PKC/JNK-dependent pathway
Xu Wang1, Ziying Zhang2, Xiuling He1
1College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot, China; Key Laboratory of Clinical Diagnosis and Treatment Techniques for Animal Disease, Ministry of Agriculture, Hohhot, China.
Abstract:
Our former studies have suggested that taurochenodeoxycholic acid (TCDCA) as a signaling molecule shows obvious anti-inflammatory and immune regulation properties. In this research, we tentatively explored the potential effects and the possible mechanism that involve in the apoptotic process in NR8383 cells induced by TCDCA. Using flow cytometry analysis, we evaluated the apoptosis rate. Gene expression levels were determined by qPCR. The expressions of protein kinase C (PKC), Jun N-terminal kinase (JNK) and their phosphorylation were measured by Western Blot. We observed the activities of caspase-3 and caspase-8 with Caspase-Glo® regent. The results demonstrated that TCDCA dramatically improved the apoptosis rate of NR8383 cells in a concentration-dependent manner. In the meantime, PKC mRNA levels and activities were significantly augmented by TCDCA treatments. In addition, JNK, caspase-3 and caspase-8 mRNA expression levels and activities were increased by TCDCA, while they were markedly decreased by specific inhibitors. We conclude that TCDCA contributes to the apoptosis through the activation of the caspase cascade in NR8383 cells, and the PKC/JNK signaling pathway may be involved in this process. These results indicate that TCDCA may be a latent effective pharmaceutical product for apoptosis-related diseases.
Insights
Taurochenodeoxycholic acid (TCDCA) promotes apoptosis in NR8383 cells by activating caspase cascades. The protein kinase C (PKC)/Jun N-terminal kinase (JNK) pathway is implicated, suggesting TCDCA
Area of Science:
- Cell Biology
- Immunology
- Pharmacology
Background:
- Taurochenodeoxycholic acid (TCDCA) is recognized for its anti-inflammatory and immune-regulating functions.
- Previous research suggests TCDCA acts as a signaling molecule with potential therapeutic applications.
Purpose of the Study:
- To investigate the effects of TCDCA on apoptosis in NR8383 cells.
- To elucidate the underlying molecular mechanisms, including the involvement of the PKC/JNK pathway and caspase activation.
Main Methods:
- Flow cytometry was used to assess apoptosis rates.
- Quantitative PCR (qPCR) determined gene expression levels.
- Western Blot analyzed protein kinase C (PKC) and Jun N-terminal kinase (JNK) expression and phosphorylation.
- Caspase-Glo® reagent measured caspase-3 and caspase-8 activities.
Main Results:
- TCDCA significantly increased NR8383 cell apoptosis in a concentration-dependent manner.
- TCDCA upregulated PKC mRNA levels and activity.
- TCDCA enhanced JNK, caspase-3, and caspase-8 mRNA expression and activity, which were reversed by specific inhibitors.
Conclusions:
- TCDCA induces apoptosis in NR8383 cells via caspase cascade activation.
- The PKC/JNK signaling pathway plays a role in TCDCA-mediated apoptosis.
- TCDCA shows potential as a therapeutic agent for apoptosis-related diseases.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Related Concept Videos
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Intrinsic Apoptotic Pathway
NF-kB-dependent Signaling Pathway
Apoptosis
